Evidence map›Paper›PMID 38580377›Full record

ArticleBMJ global health2024

Setting up a data system for monitoring malaria vaccine introduction readiness and uptake in 42 health districts in Cameroon.

Franck Mboussou, Shalom Tchokfe Ndoula, Raoul Nembot, Simon Franky Baonga, Arnaud Njinkeu, Andreas Ateke Njoh, Joseph Nsiari-Muzeyi Biey, Mohamed II Kaba, Adidja Amani, Bridget Farham and 2 more

Abstract read
In one paragraph

Article in BMJ global health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Franck MboussouVaccine Preventable Diseases, World Health Organization Regional Office for Africa, Brazzaville, Congo franckfortunm@gmail.com.ORCID 0000-0002-9062-5084
Shalom Tchokfe NdoulaMinistry of Public Health, Yaounde, Centre, Cameroon.
Raoul NembotMinistry of Public Health, Yaounde, Centre, Cameroon.
Simon Franky BaongaWorld Health Organization Country Office for Cameroon, Yaounde, Cameroon.
Arnaud NjinkeuWorld Health Organization Country Office for Cameroon, Yaounde, Cameroon.
Andreas Ateke NjohMinistry of Public Health, Yaounde, Centre, Cameroon.
Joseph Nsiari-Muzeyi BieyVaccine Preventable Diseases, World Health Organization Regional Office for Africa, Brazzaville, Congo.
Mohamed II KabaWorld Health Organization Country Office for Cameroon, Yaounde, Cameroon.
Adidja AmaniVaccine Preventable Diseases, World Health Organization Regional Office for Africa, Brazzaville, Congo.
Bridget FarhamCommunicable and Non Communicable Disease Cluster, World Health Organization Regional Office for Africa, Brazzaville, Brazzaville, Congo.
Phanuel HabimanaWorld Health Organization Country Office for Cameroon, Yaounde, Cameroon.
Benido ImpoumaCommunicable and Non Communicable Disease Cluster, World Health Organization Regional Office for Africa, Brazzaville, Brazzaville, Congo.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Three months after the first shipment of RTS,S1/AS01 vaccines, Cameroon started, on 22 January 2024, to roll out malaria vaccines in 42 districts among the most at risk for malaria. Cameroon adopted and implemented the World Health Organization (WHO) malaria vaccine readiness assessment tool to monitor the implementation of preintroduction activities at the district and national levels. One week before the start of the vaccine rollout, overall readiness was estimated at 89% at a national level with two out of the five components of readiness assessment surpassing 95% of performance (vaccine, cold chain and logistics and training) and three components between 80% and 95% (planning, monitoring and supervision, and advocacy, social mobilisation and communication). 'Vaccine, cold chain and logistics' was the component with the highest number of districts recording below 80% readiness. The South-West and North-West, two regions with a high level of insecurity, were the regions with the highest number of districts that recorded a readiness performance below 80% in the five components. To monitor progress in vaccine rollout daily, Cameroon piloted a system for capturing immunisation data by vaccination session coupled with an interactive dashboard using the R Shiny platform. In addition to displaying data on vaccine uptake, this dashboard allows the generation of the monthly immunisation report for all antigens, ensuring linkage to the regular immunisation data system based on the end-of-month reporting through District Health Information Software 2. Such a hybrid system complies with the malaria vaccine rollout principle of full integration into routine immunisation coupled with strengthened management of operations.

Indexed as

MalariaMalaria VaccinesCameroonHumansImmunizationVaccinationMalaria VaccinesHealth systemsMalariaVaccines

Identifiers

PMID38580377
PMCPMC11002407

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.